Clinical trial
Effects of Bilberry and Oat Intake on Plasma Lipid Profile, Inflammation, and Exercise Capacity in Patients With Type 2 Diabetes and/or Myocardial Infarction (BioDiaMI): a Randomized, Double-blind, Placebo-controlled Trial
NCT03620266 is registered in ClinicalTrials.gov with Ole Frobert, MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Bilberry and Oat Intake on Plasma Lipid Profile, Inflammation, and Exercise Capacity in Patients With Type 2 Diabetes and/or Myocardial Infarction (BioDiaMI): a Randomized, Double-blind, Placebo-controlled Trial
- Lead sponsor
- Ole Frobert, MD, PhD
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 30, 2021
- Completion date
- December 31, 2026
- Enrollment
- 900 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.